Sara-Bay Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $246K | Sell |
10,136
-229
| -2% | -$5.55K | 0.09% | 69 |
|
2025
Q1 | $261K | Sell |
10,365
-23
| -0.2% | -$580 | 0.12% | 70 |
|
2024
Q4 | $274K | Sell |
10,388
-300
| -3% | -$7.93K | 0.1% | 74 |
|
2024
Q3 | $309K | Sell |
10,688
-2,956
| -22% | -$85.5K | 0.11% | 73 |
|
2024
Q2 | $382K | Buy |
13,644
+1,295
| +10% | +$36.2K | 0.15% | 69 |
|
2024
Q1 | $342K | Sell |
12,349
-930
| -7% | -$25.8K | 0.15% | 70 |
|
2023
Q4 | $382K | Sell |
13,279
-148
| -1% | -$4.26K | 0.19% | 64 |
|
2023
Q3 | $445K | Sell |
13,427
-2,880
| -18% | -$95.5K | 0.23% | 51 |
|
2023
Q2 | $598K | Sell |
16,307
-634
| -4% | -$23.3K | 0.29% | 36 |
|
2023
Q1 | $691K | Sell |
16,941
-1,868
| -10% | -$76.2K | 0.35% | 31 |
|
2022
Q4 | $964K | Hold |
18,809
| – | – | 0.54% | 20 |
|
2022
Q3 | $823K | Sell |
18,809
-10
| -0.1% | -$438 | 0.46% | 23 |
|
2022
Q2 | $992K | Buy |
18,819
+97
| +0.5% | +$5.11K | 0.48% | 24 |
|
2022
Q1 | $969K | Buy |
18,722
+1,360
| +8% | +$70.4K | 0.38% | 28 |
|
2021
Q4 | $1.03M | Sell |
17,362
-94
| -0.5% | -$5.55K | 0.31% | 28 |
|
2021
Q3 | $751K | Buy |
17,456
+242
| +1% | +$10.4K | 0.29% | 31 |
|
2021
Q2 | $674K | Buy |
17,214
+56
| +0.3% | +$2.19K | 0.25% | 37 |
|
2021
Q1 | $622K | Sell |
17,158
-447
| -3% | -$16.2K | 0.25% | 38 |
|
2020
Q4 | $648K | Sell |
17,605
-741
| -4% | -$27.3K | 0.29% | 34 |
|
2020
Q3 | $639K | Buy |
18,346
+7,587
| +71% | +$264K | 0.35% | 32 |
|
2020
Q2 | $350K | Buy |
+10,759
| New | +$350K | 0.2% | 50 |
|